Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai, Brian S. White, Manorama Tripathi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler, Akihide Yoshimi, Rachel Darman, et al.
Nature Medicine (2018) Vol. 24, Iss. 4, pp. 497-504
Open Access | Times Cited: 449
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Eric Wang, Sydney X. Lu, Alessandro Pastore, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 369-384.e7
Open Access | Times Cited: 287
Aberrant RNA Splicing in Cancer
Luisa F. Escobar‐Hoyos, Katherine Knorr, Omar Abdel‐Wahab
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 167-185
Open Access | Times Cited: 284
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 194-209.e9
Open Access | Times Cited: 236
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
Molly A. Smith, Gaurav S. Choudhary, Andrea Pellagatti, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 5, pp. 640-650
Open Access | Times Cited: 204
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 197
RNA Splicing and Cancer
Eric Wang, Iannis Aifantis
Trends in cancer (2020) Vol. 6, Iss. 8, pp. 631-644
Closed Access | Times Cited: 185
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Elizabeth A. Bowling, Jarey H. Wang, Fade Gong, et al.
Cell (2021) Vol. 184, Iss. 2, pp. 384-403.e21
Open Access | Times Cited: 149
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu, Anant A. Agrawal, Andrew S. Cook, et al.
Molecular Cell (2018) Vol. 70, Iss. 2, pp. 265-273.e8
Open Access | Times Cited: 151
Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes
Hai Dang Nguyen, Wan Yee Leong, Weiling Li, et al.
Cancer Research (2018) Vol. 78, Iss. 18, pp. 5363-5374
Open Access | Times Cited: 144
Altered RNA Processing in Cancer Pathogenesis and Therapy
Esther A. Obeng, Connor Stewart, Omar Abdel‐Wahab
Cancer Discovery (2019) Vol. 9, Iss. 11, pp. 1493-1510
Open Access | Times Cited: 126
Splicing factor gene mutations in hematologic malignancies
Borja Sáez, Matthew J. Walter, Timothy A. Graubert
Blood (2016) Vol. 129, Iss. 10, pp. 1260-1269
Open Access | Times Cited: 120
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
Benjamin H. Durham, Bartlomiej Getta, Sascha Dietrich, et al.
Blood (2017) Vol. 130, Iss. 14, pp. 1644-1648
Open Access | Times Cited: 107
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications
Shalini Singh, Doaa Ahmed, Hamid Dolatshad, et al.
Leukemia (2020) Vol. 34, Iss. 9, pp. 2525-2530
Open Access | Times Cited: 83
Splicing factor mutations in hematologic malignancies
Sisi Chen, Salima Benbarche, Omar Abdel‐Wahab
Blood (2021) Vol. 138, Iss. 8, pp. 599-612
Open Access | Times Cited: 66
Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies
Giulia Biancon, Poorval Joshi, Joshua T. Zimmer, et al.
Molecular Cell (2022) Vol. 82, Iss. 6, pp. 1107-1122.e7
Open Access | Times Cited: 57
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
Khrystyna North, Salima Benbarche, Bo Liu, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 7, pp. 1103-1113
Open Access | Times Cited: 47
RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yufang Bao, Sirui Zhang, Xiaoyu Zhang, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1490-1502
Open Access | Times Cited: 23
RNA-binding proteins in cancer drug discovery
Jean B. Bertoldo, Simon Müller, Stefan Hüttelmaier
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103580-103580
Closed Access | Times Cited: 23
Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
Kenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 6
Open Access | Times Cited: 76
Targeting splicing abnormalities in cancer
Anant A. Agrawal, Lihua Yu, Peter G. Smith, et al.
Current Opinion in Genetics & Development (2017) Vol. 48, pp. 67-74
Closed Access | Times Cited: 71
RNA‐binding motif protein 39 (RBM39): An emerging cancer target
Yuewei Xu, Anke Nijhuis, Hector C. Keun
British Journal of Pharmacology (2020) Vol. 179, Iss. 12, pp. 2795-2812
Open Access | Times Cited: 62
Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders
Jamie P. Nourse, Stefano Spada, Sven Danckwardt
Biomolecules (2020) Vol. 10, Iss. 6, pp. 915-915
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top